Sodium nitroprusside decreased leukotriene C4 generation by inhibiting leukotriene C4 synthase expression and activity in hepatic ischemia-reperfusion injured rats

被引:7
|
作者
Yang, Shu-Long
Lou, Yi-Jia [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol Toxicol & Biochem Pharmaceut, Hangzhou 310031, Peoples R China
[2] Nanchang Univ, Coll Med, Dept Physiol, Nanchang 330006, Peoples R China
基金
中国国家自然科学基金;
关键词
nitric oxide; sodium nitroprusside; cysteinyl leukotrienes; leukotriene C4 synthase; microsomal glutathione-S-transferase; ischemia-reperfusion injury; liver;
D O I
10.1016/j.bcp.2006.11.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of NO on LTC4 generation during hepatic ischemia-reperfusion (I/R) are largely unclear. Sprague-Dawley rats were divided into control, I/R and sodium nitroprusside (SNP, 2.5, 5 and 10 mu g/kg/min) + I/R groups. Liver was subjected to I/R injury, saline or SNP administered intravenously. The protein expressions of LTC4 synthesis enzymes including LTC4 synthase (LTC4S), microsomal glutathione-S-transferase (mGST)2 and mGST3 were detected with immunoblotting, the LTC4 synthesis enzymes' activities and LTC4 content were measured by RP-HPLC, the mRNA expressions of inducible nitric oxide synthase (iNOS) and endogenous nitric oxide synthase (eNOS) in liver were measured by RT-PCR. Tissue injuries were assessed by serum ALT and AST and histological changes. Serum NO2- and liver tissue GSH were also examined. Compared with I/R group, SNP markedly decreased LTC4 content, LTC4S protein and iNOS mRNA levels, and the LTC4 synthesis enzymes' activities (P < 0.05), but significantly enhanced eNOS mRNA expression in liver (P < 0.05). The decline in serum ALT, AST and NO2- levels (P < 0.05) together with hepatic GSH elevation (P < 0.05) in SNP + I/R groups were also observed. LTC4S expression in hepatocytes and sinusoidal endothelial cells in SNP + I/R groups was lower than that in I/R group. But no significant differences in the protein expressions of mGST3 and mGST2 existed between control, I/R and SNP + I/R groups (P > 0.05). These results demonstrated that the decline in LTC4 production by SNP treatment during hepatic I/R could be partially resulted from SNP down-regulating the protein expression of LTC4S rather than mGST2 or mGST3 and its inhibiting the LTC4 synthesis enzymes' activities. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:724 / 735
页数:12
相关论文
共 50 条
  • [31] Change of plasma leukotriene C4 during myocardial ischemia in humans
    Takase, B
    Kurita, A
    Maruyama, T
    Uehata, A
    Nishioka, T
    Mizuno, K
    Nakamura, H
    Katsura, K
    Kanda, Y
    CLINICAL CARDIOLOGY, 1996, 19 (03) : 198 - 204
  • [32] Respiratory syncytial virus induces leukotriene C4 synthase expression in bronchial epithelial cells
    Sun, Li-hong
    Chen, Ai-huan
    Yang, Zi-feng
    Chen, Jason J.
    Guan, Wen-da
    Wu, Jie-ling
    Qin, Sheng
    Zhong, Nan-shan
    RESPIROLOGY, 2013, 18 : 40 - 46
  • [33] Leukotriene C4 synthase is a novel PPARγ target gene, and leukotriene C4 and D4 activate adipogenesis through cysteinyl LT1 receptors in adipocytes
    Fujimori, Ko
    Uno, Saki
    Kuroda, Kyohei
    Matsumoto, Chihiro
    Maehara, Toko
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2022, 1869 (03):
  • [34] Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease
    Freiberg, Jacob J.
    Tybjaerg-Hansen, Anne
    Sillesen, Henrik
    Jensen, Gorm B.
    Nordestgaard, Borge G.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (05) : 990 - 996
  • [35] Leukotriene C4 synthase:: a pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes
    Lam, BK
    Austen, KF
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 : 511 - 520
  • [36] Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase
    Daniel Martinez Molina
    Anders Wetterholm
    Andreas Kohl
    Andrew A. McCarthy
    Damian Niegowski
    Eva Ohlson
    Tove Hammarberg
    Said Eshaghi
    Jesper Z. Haeggström
    Pär Nordlund
    Nature, 2007, 448 : 613 - 616
  • [37] Novel Mutations in Leukotriene C4 Synthase and Risk of Ischemic Cardiovascular Disease
    Freiberg, Jacob
    Tybjcrg-Hansen, Anne
    Nordestgaard, Borge G.
    CIRCULATION, 2009, 120 (18) : S607 - S607
  • [38] Molecular and catalytic properties of three rat leukotriene C4 synthase homologs
    Schröder, O
    Sjöström, M
    Qiu, H
    Stein, J
    Jakobsson, PJ
    Haeggström, JZ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 312 (02) : 271 - 276
  • [39] Functional expression of single-chain antibody to leukotriene C4
    Kawakami, Yuki
    Yamashita, Chiaki
    Kashiwase, Yoshiko
    Morinaka, Tomoko
    Suzuki-Yamamoto, Toshiko
    Yamashita, Hiromi
    Kimoto, Masumi
    Tsuji, Hideaki
    Kurahashi, Yuko
    Daiyasu, Hiromi
    Toh, Hiroyuki
    Sugahara, Mitsuaki
    Miyano, Masashi
    Yamamoto, Shozo
    Takahashi, Yoshitaka
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 392 (03) : 421 - 425
  • [40] Leukotriene C4 synthase:: A candidate gene for the aspirin intolerant asthmatic phenotype
    Penrose, JF
    Baldasaro, MH
    ALLERGY AND ASTHMA PROCEEDINGS, 1999, 20 (06) : 353 - 360